TY - JOUR
T1 - Accelerated cognitive ageing in epilepsy
T2 - A neuropsychological evaluation of cognitive deterioration
AU - Breuer, Lisanne E.M.
AU - Bernas, Antoine
AU - Boon, Paul
AU - Besseling, René M.H.
AU - Carrette, Evelien C.B.
AU - de Louw, Anton
AU - Aldenkamp, Albert P.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Objective Shed light on cognitive deterioration in Accelerated Cognitive Ageing (ACA) in epilepsy from a neuropsychological point of view in order to improve clinical diagnostics. Methods We compared the IQ-profile including GAI, OPIE IV-premorbid IQ and deterioration-scores of 21 epilepsy patients with ACA with 21 matched epilepsy patients without ACA (Epilepsy Controls) and 16 age- and education-matched Healthy Controls. Memory was also evaluated. Results Premorbid IQs were equal in all groups. Deterioration was apparent in the ACA-group in the WAIS-IV FSIQ and PRI, whereas no deterioration was found in the two control groups. PSI was impaired in both epilepsy groups, though with more impairment seen in the ACA-group. The VCI remained unimpaired. The FSIQ-GAI discrepancy was equal in both patient groups and significantly larger than in the Healthy Controls. WMS-IV memory indices were of average level in all groups. Memory impairment in ACA was not statistically different from the Epilepsy Controls. 85.7% of ACA-patients could be correctly classified through factors DET-FSIQ and PSI. Conclusions Cognitive deterioration in ACA is characterized by an average drop of 19 IQ-points in FSIQ and PRI. Verbal abilities remain unimpaired. Impairments in fluid functions compromise cognitive abilities in epilepsy, but only partially contribute to cognitive deterioration in ACA. PSI proved to have some diagnostic value in differentiating epilepsy patients from healthy controls, but fails to differentiate between ACA and Epilepsy Controls. A comparison made between OPIE-IV equations and obtained IQs leads to a significant better detection of cognitive deterioration in epilepsy than the use of GAI-FSIQ discrepancies alone.
AB - Objective Shed light on cognitive deterioration in Accelerated Cognitive Ageing (ACA) in epilepsy from a neuropsychological point of view in order to improve clinical diagnostics. Methods We compared the IQ-profile including GAI, OPIE IV-premorbid IQ and deterioration-scores of 21 epilepsy patients with ACA with 21 matched epilepsy patients without ACA (Epilepsy Controls) and 16 age- and education-matched Healthy Controls. Memory was also evaluated. Results Premorbid IQs were equal in all groups. Deterioration was apparent in the ACA-group in the WAIS-IV FSIQ and PRI, whereas no deterioration was found in the two control groups. PSI was impaired in both epilepsy groups, though with more impairment seen in the ACA-group. The VCI remained unimpaired. The FSIQ-GAI discrepancy was equal in both patient groups and significantly larger than in the Healthy Controls. WMS-IV memory indices were of average level in all groups. Memory impairment in ACA was not statistically different from the Epilepsy Controls. 85.7% of ACA-patients could be correctly classified through factors DET-FSIQ and PSI. Conclusions Cognitive deterioration in ACA is characterized by an average drop of 19 IQ-points in FSIQ and PRI. Verbal abilities remain unimpaired. Impairments in fluid functions compromise cognitive abilities in epilepsy, but only partially contribute to cognitive deterioration in ACA. PSI proved to have some diagnostic value in differentiating epilepsy patients from healthy controls, but fails to differentiate between ACA and Epilepsy Controls. A comparison made between OPIE-IV equations and obtained IQs leads to a significant better detection of cognitive deterioration in epilepsy than the use of GAI-FSIQ discrepancies alone.
KW - Accelerated Cognitive Ageing
KW - Cognitive deterioration
KW - Epilepsy
KW - General Ability Index
KW - IQ
KW - Wechsler-Adult Intelligence Scale-Fourth Edition
KW - Intelligence
KW - Humans
KW - Memory
KW - Middle Aged
KW - Male
KW - Cognition
KW - Cognitive Aging/psychology
KW - Aptitude
KW - Neuropsychological Tests
KW - Epilepsy/complications
KW - Adult
KW - Female
KW - Aged
KW - Cognition Disorders/complications
UR - http://www.scopus.com/inward/record.url?scp=85059632800&partnerID=8YFLogxK
U2 - 10.1093/arclin/acy042
DO - 10.1093/arclin/acy042
M3 - Article
C2 - 29718070
AN - SCOPUS:85059632800
SN - 0887-6177
VL - 34
SP - 301
EP - 309
JO - Archives of Clinical Neuropsychology
JF - Archives of Clinical Neuropsychology
IS - 3
ER -